Home Page - Memphis Hematologic Malignancies Symposium

The Memphis Hematologic Malignancies Symposium, is a CE-accredited educational conference that convenes leading experts to provide a comprehensive review of current and emerging strategies for the management of lymphoma, multiple myeloma, and leukemia. The program is designed to enhance participants’ knowledge and clinical competence, enabling them to apply practice-changing data and expert recommendations to optimize patient care.

Through a combination of didactic presentations and interactive case-based sessions, attendees will engage with faculty to explore practical approaches for diagnosing, staging, and managing patients with hematologic malignancies. Emphasis is placed on evidence-based decision-making, multidisciplinary collaboration, and patient-centered care. Participants will gain actionable insights on novel therapies, evolving treatment algorithms, and management of treatment-related toxicities, equipping them to confidently translate the latest scientific findings into improved clinical outcomes.

This activity is intended for a multidisciplinary audience, including physicians, advanced practice providers, pharmacists, nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Memphis Riverline Hotel